Clinical trial
A Study of Patient Management in HIV-1 Infected Patients Found to Have the…
NCT00435838 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00435838 |
|---|---|
| Title | A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701 |
| Official title | A Retrospective, Multi-Centre Observational Study to Evaluate Disease Management and Adverse Events in Adult Subjects With HIV-1 Infection Who Were Withdrawn From CNA106030 Due to a Positive HLA-B*5701 Test Result |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | No Intervention -- Observational study |
| Enrollment | 35 |
| Start date | Mar 1, 2007 |
| First posted | Feb 16, 2007 |
| Last update posted | Oct 15, 2008 |
| Countries | Austria, Belgium, Italy, Russia, Slovenia, Spain, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: